Is PET the future of nuclear cardiology- why?

Please register to watch the webinar recording

Cardiovascular diseases are the leading cause of death in the United States and worldwide. In the light of the changing landscape of cardiac diseases epidemiology, conventional imaging techniques are no longer effective for diagnosis, risk assessment, and patient management . In contrast, quantitative PET provides absolute measurements that can help tackle these challenges and significantly improve patient care.

In this webinar, Dr Di Carli from Brigham and Women's Hospital and Dr. Buechel from University Hospital Zurich will explain why they believe PET imaging is the future in management of CVD.


  • The Change in Cardiovascular Diseases Epidemiology And The Evolving Role of PET

    Dr. Marcelo Fernando Di Carli

    Director of CV Imaging and Chief Division of Nuclear Medicine and Molecular Imaging at Brigham and Women's Hospital.

  • Why hasn't PET taken off despite its proven clinical value in cardiovascular disease?

    Prof. Ronny R. Buechel

    Deputy Chair of the Department of Nuclear Medicine at University Hospital Zurich and an expert in multimodality non-invasive cardiac imaging (Nuclear/CT/MRI).